Kevin A. Webster

450 total citations
8 papers, 261 citations indexed

About

Kevin A. Webster is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Kevin A. Webster has authored 8 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 3 papers in Psychiatry and Mental health. Recurrent topics in Kevin A. Webster's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Receptor Mechanisms and Signaling (5 papers). Kevin A. Webster is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Receptor Mechanisms and Signaling (5 papers). Kevin A. Webster collaborates with scholars based in United States. Kevin A. Webster's co-authors include Joseph H. Porter, James Ritchie, Daniel F. Manvich, Martilias S. Farrell, Stephanie L. Foster, David Weinshenker, Richard Young, Todd M. Hillhouse, Adam J. Prus and Herbert Y. Meltzer and has published in prestigious journals such as Scientific Reports, The FASEB Journal and Psychopharmacology.

In The Last Decade

Kevin A. Webster

8 papers receiving 260 citations

Peers

Countries citing papers authored by Kevin A. Webster

Since Specialization

Citations

This map shows the geographic impact of Kevin A. Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Webster more than expected).

Fields of papers citing papers by Kevin A. Webster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Webster. The network helps show where Kevin A. Webster may publish in the future.

Co-authorship network of co-authors of Kevin A. Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Webster. A scholar is included among the top collaborators of Kevin A. Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Webster. Kevin A. Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Discriminative stimulus properties of the typical antipsychotic haloperidol compared to other antipsychotic drugs in C57BL/6 mice 2019 ·Behavioural Pharmacology ·(unknown), Kevin A. Webster, Todd M. Hillhouse, (unknown), Joseph H. Porter	1
2	The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice 2018 ·Scientific Reports ·Daniel F. Manvich, Kevin A. Webster, Stephanie L. Foster, Martilias S. Farrell, James Ritchie, Joseph H. Porter, David Weinshenker	239
3	Translational Value of Drug Discrimination with Typical and Atypical Antipsychotic Drugs 2017 ·Current topics in behavioral neurosciences ·Joseph H. Porter, Kevin A. Webster, Adam J. Prus	2
4	Discriminative stimulus properties of the atypical antipsychotic amisulpride: comparison to its isomers and to other benzamide derivatives, antipsychotic, antidepressant, and antianxiety drugs in C57BL/6 mice 2017 ·Psychopharmacology ·(unknown), Todd M. Hillhouse, Kevin A. Webster, Richard Young, (unknown), Joseph H. Porter	7
5	Behavioral and Pharmacokinetic Properties of the Putatively‐Inert DREADD Ligand Clozapine‐N‐Oxide (CNO) in Rats and Mice 2017 ·The FASEB Journal ·Joseph H. Porter, Daniel F. Manvich, Kevin A. Webster, Stephanie L. Foster, Martilias S. Farrell, David Weinshenker	2
6	(S)-amisulpride as a discriminative stimulus in C57BL/6 mice and its comparison to the stimulus effects of typical and atypical antipsychotics 2014 ·European Journal of Pharmacology ·(unknown), Todd M. Hillhouse, Kevin A. Webster, Richard Young, (unknown), Joseph H. Porter	6
7	The metabolites N-desmethylclozapine and N-desmethylolanzapine produce cross-tolerance to the discriminative stimulus of the atypical antipsychotic clozapine in C57BL/6 mice 2011 ·Behavioural Pharmacology ·(unknown), Kevin A. Webster, Herbert Y. Meltzer, (unknown)	3
8	Very low dose neuroleptic-treatment of first episode psychosis—Is it feasible in routine clinical care? 1997 ·Schizophrenia Research ·Patrick D. McGorry, John Cocks, (unknown), Kevin A. Webster, Kathryn Elkins, Mats Hallgren, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact